DEF 14A: XTI Aerospace Seeks Shareholder Approval for Key Proposals Including Reverse Stock Split and Share Increase
Proxy Statement
XTI Aerospace is asking shareholders to vote on several key proposals at its upcoming annual meeting, including a reverse stock split and an increase in authorized shares, to maintain its Nasdaq listing and secure future financing.
Summary
- XTI Aerospace is holding its 2024 Annual Meeting of Stockholders virtually on December 27, 2024.
- The company is seeking approval for several proposals, including the election of two Class I directors, ratification of the appointment of Marcum LLP as its independent auditor, and an increase in the number of authorized shares of common stock to up to 1,000,000,000.
- A key proposal is to authorize a reverse stock split at a ratio between 1-for-2 and 1-for-250, to be determined by the Board, to comply with Nasdaq listing rules.
- The company is also seeking approval for potential issuances of common stock in non-public transactions, up to an aggregate offering amount of $20,000,000.
- Additionally, the company is requesting authorization to adjourn the annual meeting, if necessary, to solicit additional proxies.
- The record date for determining stockholders eligible to vote is November 19, 2024.
Sentiment
Score: 4
Explanation: The document highlights significant challenges, including a delisting notice and a working capital deficit, which are negative indicators. While the company is taking steps to address these issues, the overall tone is cautious and reflects a difficult financial situation.
Positives
- The proposed increase in authorized shares provides the company with flexibility for future capital raises and strategic opportunities.
- The reverse stock split, if successful, could increase the market price of the company's stock, potentially attracting more investors.
- The virtual format of the annual meeting allows for broader stockholder participation.
- The company is actively seeking to regain compliance with Nasdaq listing requirements.
Negatives
- The company received a delisting determination from Nasdaq due to its low stock price.
- The reverse stock split may not result in a sustained increase in the stock price.
- The company is operating with a working capital deficit of approximately $11.9 million.
- The company has a history of reverse stock splits to maintain its Nasdaq listing.
Risks
- There is no guarantee that the reverse stock split will increase the stock price or that the company will regain compliance with Nasdaq listing rules.
- If delisted from Nasdaq, the company's stock may trade on less efficient markets, potentially reducing liquidity and market price.
- The company's ability to raise capital may be reduced if it is delisted from Nasdaq.
- The company's stock may be subject to penny stock regulations if delisted, making transactions more difficult.
- The company is operating with a working capital deficit and may need to raise additional capital through the sale of securities.
Future Outlook
The company is seeking to regain compliance with Nasdaq listing requirements through a reverse stock split and is exploring other options. The company may need to raise additional capital to fund its operations.
Management Comments
- The Board believes that the increase in the number of authorized shares of Common Stock is necessary to provide us with resources and flexibility with respect to our capital sufficient to execute our business plans and strategy.
- The Board believes that granting this discretionary authority provides the Board with maximum flexibility to react to prevailing market conditions and future changes to the market price of our Common Stock, and therefore better enables it to act in the best interests of the Company.
Industry Context
The company's efforts to maintain its Nasdaq listing and secure financing are common challenges for companies in the aerospace and technology sectors, particularly those in the development stage. The proposed reverse stock split and share increase are typical strategies used by companies facing delisting threats.
Comparison to Industry Standards
- Many companies facing delisting from major exchanges due to low stock prices have implemented reverse stock splits to try and regain compliance, such as Cassava Sciences (SAVA) and Ocugen (OCGN).
- The proposed increase in authorized shares is a common practice for companies seeking to raise capital for growth and operations, similar to actions taken by companies like Virgin Galactic (SPCE) and Joby Aviation (JOBY).
- The potential non-public stock issuances are similar to private placements used by other companies to raise capital quickly, often at a discount to the market price, such as those seen in the biotech sector with companies like Amylyx Pharmaceuticals (AMLX).
- The use of a virtual annual meeting is becoming increasingly common, especially for companies with a geographically dispersed shareholder base, as seen with companies like Zoom Video Communications (ZM) and DocuSign (DOCU).
Stakeholder Impact
- Shareholders face the risk of further dilution and potential loss of value if the company is delisted.
- Employees may be impacted by the company's financial instability and potential restructuring.
- Customers and suppliers may be affected by the company's ability to continue operations and fulfill its obligations.
- Creditors face the risk of non-payment if the company's financial situation does not improve.
Next Steps
- The company will hold its annual meeting on December 27, 2024, to vote on the proposed resolutions.
- The company will submit a plan to the Nasdaq Hearings Panel to regain compliance with listing rules.
- The company may implement a reverse stock split if approved by stockholders and deemed necessary by the Board.
- The company may pursue non-public stock issuances to raise capital.
Key Dates
| Date | Description |
|---|---|
| July 9, 2024 | Company received a deficiency letter from Nasdaq for not meeting the minimum bid price requirement. |
| November 7, 2024 | Company received a delisting letter from Nasdaq due to its stock price falling below $0.10 per share. |
| November 14, 2024 | Company requested a hearing before a Nasdaq Hearings Panel to appeal the delisting determination. |
| November 19, 2024 | Record date for determining stockholders eligible to vote at the annual meeting. |
| December 3, 2024 | Date of the proxy statement. |
| December 27, 2024 | Date of the 2024 Annual Meeting of Stockholders. |
| January 6, 2025 | Original deadline to regain compliance with Nasdaq minimum bid price requirement. |
| January 9, 2025 | Date of the hearing before the Nasdaq Hearings Panel. |
Keywords
reverse stock split, authorized shares, Nasdaq listing, delisting, stock issuance, annual meeting, proxy vote, capital raise, financing, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.